FDA panel supports over-the-counter birth control pill, paving way for final, US approval
Thursday, May 11, 2023 | Tag Cloud | Learn about our FREE SYNDICATION Service | Sign up for our Worthy Briefs!
(Worthy News) – An advisory panel at the U.S. Food and Drug Administration on Wednesday said that a decades-old birth control pill should be sold without a prescription, paving the way for the first over-the-counter contraceptive pill to be approved nationally.
In a unanimous vote, the FDA advisers supported pharmaceutical manufacturer Perrigo’s request to sell its daily birth control pill, Opill, over the counter.
The recommendation is non-binding, but if the FDA follows it, then Opill would become the first contraceptive medication to be moved from a prescription-only basis to the store shelves. [ Source: Just the News (Read More…) ]
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.